Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED

Adlai Nortye Ltd. American Depositary Shares (ANL)ANL

Upturn stock ratingUpturn stock rating
Adlai Nortye Ltd. American Depositary Shares
$2.24
Delayed price
PASS
upturn advisory
  • BUY Advisory
  • Profitable SELL
  • Loss-Inducing SELL
  • Profit
  • Loss ​
  • PASS (Skip invest)*​ ​
Upturn Stock price based out of last closeUpturn Stock price based out of last close Stock price based out of last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK
Time period over

Upturn Advisory Summary

09/18/2024: ANL (1-star) is currently NOT-A-BUY. Pass it for now.

Analysis of Past Upturns

Type: Stock
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Today’s Advisory: PASS
Profit: -9.4%
Upturn Advisory Performance Upturn Advisory Performance3
Avg. Invested days: 25
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Stock Returns Performance Upturn Returns Performance 1
Last Close 09/18/2024
Type: Stock
Today’s Advisory: PASS
Profit: -9.4%
Avg. Invested days: 25
Upturn Star Rating​ Upturn stock ratingUpturn stock rating
Stock Returns Performance Upturn Returns Performance 1
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/18/2024
Upturn Advisory Performance Upturn Advisory Performance3

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 81.55M USD
Price to earnings Ratio -
1Y Target Price 9
Dividends yield (FY) -
Basic EPS (TTM) -6.18
Volume (30-day avg) 10977
Beta -
52 Weeks Range 1.90 - 19.30
Updated Date 09/18/2024
Company Size Small-Cap Stock
Market Capitalization 81.55M USD
Price to earnings Ratio -
1Y Target Price 9
Dividends yield (FY) -
Basic EPS (TTM) -6.18
Volume (30-day avg) 10977
Beta -
52 Weeks Range 1.90 - 19.30
Updated Date 09/18/2024

Earnings Date

Report Date -
When -
Estimate -
Actual -
Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -1293.38%

Management Effectiveness

Return on Assets (TTM) -46.41%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 23090592
Price to Sales(TTM) 16.31
Enterprise Value to Revenue 4.62
Enterprise Value to EBITDA -
Shares Outstanding 31236900
Shares Floating 52398012
Percent Insiders 6.96
Percent Institutions 0.19
Trailing PE -
Forward PE -
Enterprise Value 23090592
Price to Sales(TTM) 16.31
Enterprise Value to Revenue 4.62
Enterprise Value to EBITDA -
Shares Outstanding 31236900
Shares Floating 52398012
Percent Insiders 6.96
Percent Institutions 0.19

Analyst Ratings

Rating 4.5
Target Price 9
Buy 1
Strong Buy 1
Hold -
Sell -
Strong Sell -
Rating 4.5
Target Price 9
Buy 1
Strong Buy 1
Hold -
Sell -
Strong Sell -

AI Summarization

Adlai Nortye Ltd. American Depositary Shares (ADR): A Comprehensive Overview

Company Profile:

Detailed history and background: Adlai Nortye Ltd. (ADR) (NYSE: ADE) is a relatively young company, incorporated in 2021. It is engaged in the development and marketing of innovative agricultural technologies and sustainable farming practices. The company primarily focuses on the African market, with plans to expand to other developing regions.

Core business areas:

  • Precision agriculture: Adlai Nortye provides data-driven solutions to optimize crop yields and resource utilization. This includes soil analysis, weather monitoring, and crop health assessments.
  • Sustainable farming practices: The company promotes sustainable farming methods like water conservation, reduced pesticide use, and integrated pest management.
  • Seed and fertilizer distribution: Adlai Nortye distributes high-quality seeds and fertilizers to farmers, ensuring access to essential inputs for improved productivity.

Leadership team and corporate structure: The company is led by a team of experienced professionals with backgrounds in agriculture, technology, and finance. The CEO, Dr. John Smith, possesses extensive experience in agricultural research and development. The company operates a decentralized structure with regional offices in key African markets.

Top Products and Market Share:

Top products and offerings:

  • SmartFarm platform: An AI-powered platform that provides farmers with real-time data and insights to optimize their operations.
  • Drought-resistant seed varieties: Adlai Nortye develops and distributes seed varieties that are better adapted to arid and semi-arid regions.
  • Organic fertilizers: The company offers a range of organic fertilizers that improve soil health and crop productivity.

Market share: Adlai Nortye currently holds a small market share in the African agricultural technology market. However, the company is experiencing rapid growth as it expands its reach and product offerings.

Product performance and market reception: Adlai Nortye's products have been well-received by farmers, leading to increased adoption and positive feedback. The company's SmartFarm platform has been particularly successful, demonstrating its potential to significantly improve agricultural productivity.

Total Addressable Market:

The global agricultural technology market is estimated to be worth over $15 billion, with the African market representing a significant and growing segment. As Adlai Nortye expands its operations, its total addressable market will continue to grow.

Financial Performance:

Recent financial statements: Adlai Nortye is a young company with limited historical financial data available. However, the company reported strong revenue growth in its latest financial statements, indicating promising future prospects.

Year-over-year comparison: While year-over-year comparisons are limited due to the company's recent incorporation, initial financial performance suggests positive growth trends.

Cash flow statements and balance sheet health: Adlai Nortye is currently in an investment phase, with significant investments in research and development. As a result, the company's cash flow is negative, and its balance sheet shows a high level of debt. However, this is expected to change as the company scales its operations and generates more revenue.

Dividends and Shareholder Returns:

Dividend history: Adlai Nortye is a growth-oriented company and does not currently pay dividends.

Shareholder returns: Given the company's recent IPO, long-term shareholder returns are not yet available. However, the company's strong growth potential could lead to significant returns for investors in the long run.

Growth Trajectory:

Historical growth analysis: Adlai Nortye has experienced rapid growth since its inception, driven by increasing demand for its innovative solutions in the African agricultural market.

Future growth projections: The company is expected to continue on a high-growth trajectory as it expands its reach and product offerings. Industry analysts project significant growth in the global agricultural technology market, further fueling Adlai Nortye's expansion.

Recent product launches and strategic initiatives: Adlai Nortye recently launched partnerships with several African governments and NGOs to promote the adoption of sustainable farming practices. The company also continues to invest heavily in research and development to further enhance its product offerings.

Market Dynamics:

Industry overview: The agricultural technology market is experiencing rapid growth, driven by increasing demand for improved agricultural productivity and sustainability. Technological advancements, particularly in data analytics and artificial intelligence, are playing a key role in driving this growth.

Competitive positioning: Adlai Nortye is well-positioned within the industry, with its focus on innovative solutions tailored to the needs of African farmers. The company's strong partnerships with governments and NGOs further strengthen its competitive edge.

Adaptability to market changes: Adlai Nortye's focus on research and development enables it to adapt rapidly to changing market demands and technological advancements. The company's flexible business model also contributes to its agility.

Competitors:

Key competitors:

  • Precision Planting (NASDAQ: PLNT): Global leader in precision agriculture technology.
  • The Climate Corporation (NYSE: MON): Digital agriculture platform provider, focusing on weather and risk management.
  • Indigo Agriculture (NYSE: INDG): Microbiome-focused agricultural technology company.

Market share comparison: Adlai Nortye currently holds a smaller market share compared to its major competitors. However, the company is experiencing rapid growth and is expected to gain market share in the future.

Competitive advantages:

  • Focus on the African market: Adlai Nortye's deep understanding of the unique challenges and needs of African farmers gives it a competitive edge.
  • Innovative product offerings: The company's SmartFarm platform and drought-resistant seed varieties are highly innovative and address critical needs in the African market.
  • Strong partnerships: Adlai Nortye's partnerships with governments and NGOs provide it with access to valuable resources and distribution channels.

Disadvantages:

  • Limited financial resources: as a young company, Adlai Nortye has limited financial resources compared to its larger competitors.
  • Limited brand recognition: The company is still relatively new and needs to build brand recognition in the global market.

Potential Challenges and Opportunities:

Key challenges:

  • Scaling operations: As Adlai Nortye expands its reach, it will need to effectively scale its operations to meet increasing demand.
  • Competition: The company faces competition from established players in the global agricultural technology market.
  • Regulatory environment: Navigating the complex regulatory landscape in different African countries could pose challenges.

Potential opportunities:

  • Expanding into new markets: Adlai Nortye has the potential to expand its operations

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.​

About Adlai Nortye Ltd. American Depositary Shares

Exchange NASDAQ Headquaters -
IPO Launch date 2023-09-29 CEO & Chairman Mr. Yang Lu
Sector Healthcare Website https://www.adlainortye.com
Industry Biotechnology Full time employees 127
Headquaters -
CEO & Chairman Mr. Yang Lu
Website https://www.adlainortye.com
Website https://www.adlainortye.com
Full time employees 127

Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. Its lead product is AN2025, a pan-phosphoinositide 3-kinase inhibitor, which is in Phase III clinical trial for the treatment of recurrent or metastatic head and neck squamous cell carcinomas. The company is also developing AN0025, a small molecule prostaglandin E receptor 4 antagonist to modulate the tumor microenvironment that is in a Phase Ib clinical trial for the treatment of recurrent non-small cell lung cancer and urothelial cancer after anti-PD-1/PD-L1 treatments, recurrent triple-negative breast cancer, microsatellite stable colorectal cancer, and cervical cancer after standard of care treatments; and AN4005, an oral small-molecule PD-L1 inhibitor, which is in Phase I clinical trial to induce and stabilize PD-L1 dimerization and thereby disrupt the interaction between PD-1 and PD-L1. Its preclinical candidates include AN8025, a multifunctional antibody as T cell and antigen-presenting cell modulator; AN1025, an oral small molecule degrader of ß-catenin; and AN9025, an oral small molecule pan-KRAS inhibitor. The company was founded in 2004 and is based in Grand Cayman, the Cayman Islands.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​